Insider · CIK 0001827722

Goldberg Andrew D.

Reports to the SEC for 2 companies · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001827722

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-25	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,837 sh	—	—	3,837
2026-06-25	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,417 sh	—	—	2,417
2026-06-12	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,954 sh	—	—	19,654
2026-06-12	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,954 sh	—	—	0
2026-04-18	ACHVACHIEVE LIFE SCIENCES, INC. · Restricted Stock Unit (RSU)A Award	Director, CEO and President	AAward	+1.8M sh	—	—	1,800,965
2026-04-18	ACHVACHIEVE LIFE SCIENCES, INC. · Performance Restricted Stock Unit (PRSU)A Award	Director, CEO and President	AAward	+11.7M sh	—	—	11,706,270
2026-04-18	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Director, CEO and President	AAward	+3.6M sh	—	—	3,601,929
2025-06-13	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,350 sh	—	—	16,700
2025-06-13	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,350 sh	—	—	0
2025-06-12	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,540 sh	—	—	4,540
2025-06-12	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,954 sh	—	—	2,954
2025-03-07	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,000 sh	$12.89	+$90.2K	13,350
2025-03-07	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,000 sh	—	—	0
2024-06-24	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,350 sh	—	—	6,350
2024-06-24	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,350 sh	—	—	0
2024-06-13	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+3,350 sh	—	—	3,350
2024-06-13	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-12-15	TARSTarsus Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+1,000 sh	$18.96	+$19K	3,000
2023-06-22	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-06-22	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+3,350 sh	—	—	3,350
2023-06-16	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	0
2023-06-16	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	—	—	2,000
2022-06-16	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2022-06-16	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,000 sh	—	—	2,000
2021-06-15	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-06-15	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500

Recent filings

Accepted (ET)
Jun 294
Goldberg Andrew D.0001827722-26-000004
SEC(opens sec.gov)
Jun 164
Goldberg Andrew D.0001827722-26-000002
SEC(opens sec.gov)
Apr 214
Goldberg Andrew D.0001193125-26-167418
SEC(opens sec.gov)
Jun 164
Goldberg Andrew D.0001819790-25-000092
SEC(opens sec.gov)
Mar 114
Goldberg Andrew D.0001819790-25-000030
SEC(opens sec.gov)
Jun 254
Goldberg Andrew D.0001819790-24-000103
SEC(opens sec.gov)
Jun 144
Goldberg Andrew D.0001819790-24-000085
SEC(opens sec.gov)
Dec 194
Goldberg Andrew D.0001827722-23-000002
SEC(opens sec.gov)
Jun 264
Goldberg Andrew D.0001819790-23-000058
SEC(opens sec.gov)

Companies

Address

C/O TARSUS PHARMACEUTICALS, INC. 17700 LAGUNA CANYON ROAD, FLOOR 4

IRVINE, CA, 92618